(Q36234513)

12 August 2017

1 reference

title

Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women (English)

1 reference

12 August 2017

Lê MG

1

1 reference

12 August 2017

Cabanes PA

2

1 reference

12 August 2017

Desvignes V

3

1 reference

12 August 2017

Chanteau MF

4

1 reference

12 August 2017

Mlika N

5

1 reference

12 August 2017

Avril MF

6

1 reference

12 August 2017

publication date

1 May 1992

1 reference

12 August 2017

published in

Cancer Causes & Control

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

199-205

1 reference

A case-control study of the possible association between oral contraceptives and malignant melanoma

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00124252

Malignant melanoma and oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00124252

Oral contraceptive use and malignant melanoma in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00124252

Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00124252

Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00124252

The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00124252

Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody

21 January 2018

1 reference

12 December 2020

Oral contraceptive use and malignant melanoma.

1 reference

12 December 2020

Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use

1 reference

12 December 2020

The impact of confounder selection criteria on effect estimation

1 reference

12 December 2020

Cutaneous melanoma in relation to exogenous hormones and reproductive factors.

1 reference

12 December 2020

Malignant melanoma and oral contraceptive use among women in California

1 reference

12 December 2020

[Estrogen and progesterone receptors in malignant melanoma, benign pigmented nevi and basocellular epithelioma]

1 reference

12 December 2020

Oestrogen receptors in human malignant melanoma

1 reference

12 December 2020

The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation

1 reference

12 December 2020

Estimation of multiple relative risk functions in matched case-control studies

1 reference

12 December 2020

Cutaneous melanoma and oral contraceptives: a review of case-control and cohort studies

1 reference

12 December 2020

Estrogen receptors in patients with malignant melanoma

1 reference

12 December 2020

Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators

1 reference

12 December 2020

Estrogen and progesterone receptors and tamoxifen in malignant melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00124252

1 reference

12 August 2017

1 reference